Inhibrx Biosciences reveals preliminary data from Phase 1 trial of ozekibart (INBRX-109) in combination with FOLFIRI for the treatment of advanced or metastatic, unresectable colorectal adenocarcinoma  $INBX, #Inhibrx, #InhibrxBiosciences, #InhibrxBio
#inbx
#INBX #Inhibrx #InhibrxBiosciences #InhibrxBio